Clausen SA it is essential to ensure
that we provide safe, effective
and high quality drugs, reason why,
it is important to promote an institutional
pharmacovigilance program. To accomplish
this goal, we have created a multidisciplinary
Department where physicians and
pharmaceutics chemists work together.
The commitment with our products
does not end when they are marketed,
but is rather a continuous and permanent
What is pharmacovigilance?
Pharmacovigilance is concerned with the identification, assessment and prevention of risks associated with drugs once marketed.
Its main objectives are:
1. Early detection of adverse reactions and interactions so far unknown.
2. The detection of increased frequency of adverse reactions (known).
3. The estimate of the quantitative aspects of risk/benefit ratio and the diffusion of needed information to improve the regulation and
In order to continue to improve we have created a space to send us any questions you may have about our products. The members of the Pharmacovigilance Department will answer you.
The information you send is confidential.
References: Uppsala Monitoring Centre, World Health Organization